Source: Clinical Laboratory News
Omicia, a provider of clinical genomic data analysis and reporting software, has acquired bioinformatics company Spiral Genetics. Omicia offers a range of next-generation sequencing (NGS) analysis capabilities to support high-throughput panels, exomes, and whole genomes for identifying hereditary diseases and somatic cancer and delivering clinical reports directly into electronic medical record workflows. With the acquisition of Spiral, Omicia plans to add multiple variant detection capabilities for NGS to its software platform. Spiral’s graph-based technology enables accurate detection of structural variants and provides population-scale data-mining capabilities for clinical laboratories, life science companies, and country sequencing programs. Also included in the acquisition are Spiral’s population-specific reference genome and lossless data compression technologies. Omicia expects this to open up new opportunities to develop novel diagnostics and efficiently manage long-term genomic data storage.